2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Body Fat Disorder: new trials by email Literature Review of Body Fat Disorder trials Research Report on Body Fat Disorder
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Contribution of Dolutegravir to Obesity and Cardiovascular Disease Dolutegravir 50 MG, Antiretroviral/Anti HIV - HIV-1-infection, Antiviral Drug Adverse Reaction | Phase 4 | Completed | Augusta University | 10 | 2020-09-17 | 2023-07-27 |
| Submental Study (Sequential Treatment Approach) The ZELTIQ CoolSculpting System, Kybella 20 MG in 2 ML Injection - Body Fat Disorder | Phase 4 | Completed | Zeltiq Aesthetics | 16 | 2018-03-27 | 2021-12-30 |
Body Weight Changes (1) · Cardiovascular Abnormalities (1) · HIV-Associated Lipodystrophy Syndrome (1) · Vascular Diseases (1)
Blood-Borne Infections (1) · Body Weight (1) · Cardiovascular Diseases (1) · Communicable Diseases (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genital Diseases (1) · HIV Infections (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infections (1) · Lentivirus Infections (1) · Lipid Metabolism Disorders (1) · Lipodystrophy (1) · Metabolic Diseases (1)
Cobicistat (1) · Darunavir (1) · Deoxycholic Acid (1) · Injections (1) · Lamivudine (1) · Rilpivirine (1) · Tenofovir (1) · Zidovudine (1) · abacavir (1) · dolutegravir (1) · lamivudine, zidovudine drug combination (1) · tenofovir alafenamide (1)
Augusta University (1) · Zeltiq Aesthetics (1)
United States (2)
Jonell B Poe, MPAS (1) · Kerrie Jiang, NP (1)